Paper Tools Add to my Library Share How would you like to share? Facebook Twitter LinkedIn Back to the Top
Mullard A. Biogen files ALS drug for FDA review, putting neuroscience-accelerated approvals back in the hot seat. Nat Rev Drug Discov. 2022 Sep;21(9):626. PubMed. Recommends Please login to recommend the paper. Comments No Available Comments Make a Comment To make a comment you must login or register.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.